SS Innovations International, Inc.
SSIINasdaqHealthcare · Surgical & Medical Instruments & Apparatus · FL · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $42.5M | $20.6M | $5.9M | — | — | — |
| Operating income | −$8.2M | −$19.0M | −$20.3M | −$5.7M | — | — |
| Net income | −$12.1M | −$19.2M | −$20.9M | −$5.6M | −$1.5M | −$1.1M |
| Total assets | $74.2M | $42.4M | $31.5M | $8.7M | $428,607 | $317,870 |
| Total liabilities | $36.0M | $28.9M | $11.8M | $11.1M | — | — |
| Equity | $38.2M | $13.5M | $19.7M | −$2.7M | −$166,380 | −$869,049 |
| EPS (diluted) | $-0.06 | $-0.11 | $-0.14 | $-0.14 | $-0.05 | $-0.05 |
| Shares out. | 193.6M | 170.7M | 53.9M | 39.2M | 37.8M | 25.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −19.3%
- Net margin
- −28.5%
- Return on equity
- −31.7%
- Return on assets
- −16.3%
- Return on capital (ROCE)
- −17.1%
- Liabilities / assets
- 48.5%
- Debt / equity
- 0.94×
- Book value / share
- $0.20
- Revenue growth (YoY)
- 105.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -0.08distress
- Accruals / assets
- 8.6%moderate
- Beneish M-Score
- -0.77elevated
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Beneish M-Score elevated — earnings-manipulation screen flag
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
- NT 10-Kmissed a reporting deadline ↗May 15, 2020
- NT 10-Kmissed a reporting deadline ↗Mar 29, 2019
- NT 10-Qmissed a reporting deadline ↗May 15, 2018
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Sudhir SrivastavaPassive (13G)May 4, 2026
- Moll Frederic HPassive (13G)May 15, 2025
- Cohen Barry FPassive (13G)Feb 13, 2025
- Pai Ranjan RPassive (13G)Feb 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 58,021 | 1.2 | +17.9% |
| Apr 30, 2026 | 49,199 | 1.2 | -34.0% |
| Apr 15, 2026 | 74,555 | 1.6 | -49.8% |
| Mar 31, 2026 | 148,402 | 3.1 | -30.6% |
| Mar 13, 2026 | 213,820 | 2.5 | -14.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeMay 26, 2026
- Results of operations · Regulation FD disclosureMay 13, 2026
- Other material eventMay 7, 2026
- Other material eventMay 5, 2026
- Regulation FD disclosureApr 23, 2026
- Other material eventApr 7, 2026
- Other material eventMar 30, 2026
- Other material eventMar 18, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KCURRENT REPORTMay 26, 2026
- 424B5PROSPECTUSMay 20, 2026
- EFFECTMay 18, 2026
- 4May 13, 2026
- 8-KCURRENT REPORTMay 13, 2026
- 10-QQUARTERLY REPORTMay 13, 2026
- 8-KCURRENT REPORTMay 7, 2026
- 8-KCURRENT REPORTMay 5, 2026
- SCHEDULE 13G/AMay 4, 2026
- S-3REGISTRATION STATEMENTMay 1, 2026
- 8-KCURRENT REPORTApr 23, 2026
- RWWITHDRAWAL REQUESTApr 20, 2026
- 4Apr 15, 2026
- 8-KCURRENT REPORTApr 7, 2026
- 4Apr 6, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.